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A B S T R A C T
Background: Prenatal exposure to endocrine-disrupting chemicals may impair genital development and alter
reproductive tract anatomy. Anogenital distance (AGD) is a useful biomarker of exposure to chemicals that act as
endocrine disruptors. We evaluated associations between prenatal and perinatal exposure to several persistent
organic pollutants (POPs) and AGD in 4-year-old children.
Methods: Data were drawn from the INMA-Asturias cohort. Pediatricians measured the anofourchetal distance in
female children and anoscrotal distance in male children. The anogenital index (AGI) was defined as the AGD
divided by the child's weight at age of examination. We measured the levels of two hexachlorocyclohexane
isomers, hexachlorobenzene, dichlorodiphenyltrichloroethane (DDT) and its metabolites, six polychlorinated
biphenyl (PCB) congeners, and six polybrominated diphenyl ether (PBDE) congeners in maternal serum at 12
gestational weeks (n = 155) and in cord blood serum (n = 229). Anthropometric and parental socio-
demographic variables were collected via face-to-face interviews. Linear regression models were used to eval-
uate the relationship between exposure to POPs and AGI, adjusted for confounders and stratified by sex.
Results: In male children, we found inverse associations between AGI and maternal concentrations of PCB-138
(ß = −0.041, 95% confidence interval [CI]: −0.074, −0.008, second tertile), PCB-153 (ß = −0.052, 95% CI:
−0.085, −0.020, second tertile), PCB-180 ß =−0.065, 95% CI: −0.096, −0.035, second tertile; ß =−0.042,
95% CI: −0.073, −0.011, third tertile), PBDE-209 (ß = −0.031, 95% CI: −0.058, −0.006), cord serum
concentrations of PCB-153 (ß = −0.029, 95% CI: −0.059, −0.000, second tertile; ß = −0.047, 95% CI:
−0.085, −0.008, third tertile), and PCB-180 (ß = −0.041, 95% CI: −0.078, −0.005, third tertile). In female
children, AGI was positively associated with maternal serum concentrations of PCB-101 (ß = 0.039, 95% CI:
0.002, 0.076, second tertile), and higher cord serum levels of 4,4′-DDT (ß = 0.032, 95% CI: 0.003, 0.061, third
tertile) and 4,4′-DDE (ß = 0.040, 95% CI: 0.011, 0.069, third tertile).
Conclusions: Our findings provide evidence of associations between specific POPs and AGI in boys and girls aged
4 years, and suggest that pre/perinatal exposure to POPs has a feminizing effect in males and a masculinizing
effect in females.
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Anogenital distance (AGD) is the distance from the anus to the
genital tubercle, and is an anthropometric parameter that has been
validated in animal models as a sensitive marker of intrauterine ex-
posure to estrogens, androgens, and anti-androgens (McIntyre et al.,
2001; Wolf et al., 2004). AGD is sexually dimorphic across numerous
animal species, and males typically have a longer AGD than females at a
2:1 ratio (Barrett et al., 2014; Dean and Sharpe, 2013; McIntyre et al.,
2001). Male genital anomalies (e.g., hypospadias, cryptorchidism, tes-
ticular cancer, and declining semen quality) are features of testicular
dysgenesis syndrome (Skakkebaek et al., 2001). These characteristics
have been related to a shorter AGD (Drake et al., 2009; Singal et al.,
2016; Thankamony et al., 2014) and prenatal exposure to endocrine-
disrupting chemicals (EDCs) that act as anti-androgens during the
masculinization programming window. This refers to a period that
occurs at 9–12 gestational weeks, within which androgen action can be
affected (Dean and Sharpe, 2013; Skakkebaek et al., 2001). It has also
been suggested that female infants with congenital adrenal hyperplasia
(Callegari et al., 1987), and young adult women with higher testos-
terone levels (Mira-Escolano et al., 2014) or multifollicular ovaries
(Mendiola et al., 2012) may have a longer AGD. Therefore, AGD may be
a biomarker of prenatal exposure to EDCs and a potential predictor of
reproductive sequelae in females (Barrett et al., 2017).
Extensive toxicological literature supports the relationship between
environmental EDCs (e.g., phthalates, dioxins, and herbicides) and
shortened AGD in male animals (Hass et al., 2007; Jin et al., 2008;
Rosenberg et al., 2008; Saillenfait et al., 2009). In female rodents, in
utero exposure to 2,3,7,8-tetrachlorodibenzeno-p-dioxin can alter re-
productive morphology and function (Gray and Ostby, 1995). In addi-
tion, estrogen has a role in the development of external genitalia (Yang
et al., 2010), and when androgens were administered to a pregnant dam
it was observed that female offspring had a longer, more masculine
AGD than controls (Hotchkiss et al., 2007). Female genital anomalies
(e.g. endometriosis) have been related to an intrauterine origin, and the
role of early-life influences, such as hormonal environmental exposure
to estrogens in the uterus, are consider as risk factor for endometriosis
in adulthood (Sánchez-Ferrer et al., 2017).
A key aspect of assessing the adverse health effects of EDCs is un-
derstanding their biological mechanisms of action, especially in early
gestation. A few epidemiological studies have investigated the asso-
ciation between fetal exposure to chemicals with estrogenic or anti-
androgenic properties, including non-persistent organic pollutants such
as phthalates (Huang et al., 2009; Swan et al., 2015, 2005; Wenzel
et al., 2018), bisphenol A (BPA) (Barrett et al., 2017; Miao et al., 2011),
and non-persistent pesticides (Dalsager et al., 2018) and the AGD of
male newborns and children. In contrast, little attention has been paid
to the effects of persistent organic pollutants (POPs) on genital devel-
opment. POPs include several chemical families, such as poly-
brominated diphenyl ethers (PBDEs), organochlorine (OC) pesticides,
and polychlorobiphenyls (PCBs). Although the synthesis of these POPs
was banned by the Stockholm Convention in 2009 (SCOPS, 2009), they
have persisted in the environment and remain present in human tissues
because of their high lipophilicity and biomagnifying properties
(Carrizo et al., 2006; Casas et al., 2015; Vizcaino et al., 2014a, 2014b).
All POPs are environmental toxicants previously used as flame re-
tardants, dielectrics in transformers, or pesticides (De Wit, 2002;
Vizcaino et al., 2010), and some exhibit anti-androgenic or estrogenic
properties (Gray, 2001; Kaya et al., 2002; Portigal et al., 2002). It is
important to note that androgen and estrogen receptors are needed
differentially in males and females for the development of male or fe-
male external genitalia morphology (Yang et al., 2010). Only four
studies have evaluated the effect of prenatal exposure to di-
chlorodiphenyltrichloroethane (DDT) and dichlorodiphenyldi-
chloroethylene (DDE) on human AGD; these studies reported incon-
sistent results (Bornman et al., 2016; Longnecker et al., 2007; Loreto-
Gómez et al., 2018; Torres-Sanchez et al., 2008). To date, only one
human study has evaluated the association between PCB concentrations
and AGD in both sexes, and reported an inverse association between
AGD and levels of PCB-28, PCB-74, and PCB-170 in boys during the first
year of life (Loreto-Gómez et al., 2018). In addition, a birth cohort study
in China reported an inverse association between cord plasma con-
centrations of PBDE-47 and AGD measured in boys over the first 48
months of life (Luan et al., 2019). Another study from Denmark re-
ported an inverse association between perfluoroalkyl substances and
AGD in girls (Lind et al., 2017).
Early exposure to POPs may have estrogenic or anti-androgenic
effects, but there is no clear scientific evidence linking exposure to OC
compounds or PBDE to changes in AGD. We previously reported an
inverse association between prenatal exposure to PBDEs and AGD
among boys aged 18 months (García-Villarino et al., 2018). In the
present study, we evaluated the association of AGD and prenatal and
perinatal exposure to two hexachlorocyclohexane (HCH) isomers,
hexachlorobenzene (HCB), DDT and its derivates, six PCB congeners,
and six PBDE congeners in 4-year-old boys and girls.
2. Methods
2.1. Study design and population
The INMA (INfancia y Medio Ambiente [Environment and
Childhood]) Asturias study included a population-based cohort of
women from nine municipalities in Asturias, northern Spain. Details of
this cohort have been published elsewhere (Fernández-Somoano et al.,
2011; Fernández-Somoano and Tardon, 2014; Riaño-Galán et al.,
2017). Briefly, 494 pregnant women were recruited for the cohort be-
tween May 2004 and June 2007. The inclusion criteria were: age ≥16
years, singleton pregnancy, enrolment at 10–13 weeks of gestation, no
assisted conception, delivery scheduled at the reference hospital (Hos-
pital San Agustin in Aviles), and no communication disability. The
women completed two detailed questionnaires on anthropometric and
sociodemographic characteristics and lifestyle information, and 308
blood samples were collected. Deliveries took place between October
2004 and February 2008. In total, 485 children were born, and 326
cord blood samples were successfully collected. Follow-up was con-
ducted at 4 years for 453 children via questionnaires on environmental
health data, diet, and sociodemographic characteristics. Pediatricians
examined the children, collected blood samples, and recorded anthro-
pometric measures and sexual development. AGD was measured in 382
children at the 4-year follow up; from those children, and POPs con-
centrations were measured in 155 maternal and 229 cord serum sam-
ples (Fig. 1). The background characteristics of excluded children did
not differ markedly from those included in this study (Table S1). The
Asturias Regional Clinic Research Ethics Committee approved the re-
search protocol. All parents provided written informed consent before




Whole cord blood samples (72.16% recovery rate) were collected
using venipuncture of cord vessels before the placenta was delivered.
Maternal blood samples (95.14% recovery rate) were collected during
the first trimester of gestation (median: 12 weeks; range: 10–13 weeks)
from 308 pregnant women by trained nurses following the INMA pro-
tocol. Five milliliters of venous blood were collected from each woman
using a glass syringe and Vacutainer blood collection tubes. Blood
samples were stored in the dark at 4 °C 1–2 h after collection, and then
centrifuged for 15 min at 2,500–3,000 rpm. The serum obtained was
aliquoted into 2-ml glass cryotubes and stored at −80 °C. We measured
the concentrations of β-HCH, γ-HCH (lindane), HCB, 4,4′-DDT, 4,4′-
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DDE, 4,4′-dichlorodiphenyldichloroethane (DDD), six PCB congeners
(PCB-28, -101, −118, −153, −138, and −180), and six PBDE con-
geners (PBDE-28, -47, −99, −153, −154, and −209) in maternal and
cord serum samples. Samples were analyzed at the Barcelona Institute
of Environmental Assessment and Water Research (IDAEA–CSIC) as
previously described (Gari and Grimalt, 2010; Grimalt et al., 2010b;
Vizcaino et al., 2009).
2.2.2. Laboratory analyses
One milliliter of serum was spiked with the surrogate standards
tetrabenzene and decachlorobiphenyl and vortex-stirred for 30 s at
2,000 rpm. n-Hexane (3 ml) was added, followed by concentrated sul-
furic acid (2 ml). After reacting, the mixture was stirred for 30 s and the
supernatant n-hexane phase was separated by centrifugation. The ex-
tract was transferred to gas chromatography vials using four 25-μl
isooctane rinses for instrumental analysis. PCB-142, BDE-118 (20 μl),
and [13C]-BDE-209 (10 μl) were added as internal standards before
injection. Compound analysis was performed by gas chromatography
with electron capture detection (Agilent Technologies 6890N gas
chromatograph; Santa Clara, CA, USA), using a DB-5 column protected
by a retention gap (60 m × 0.25 mm I.D., 0.25-μm film thickness; J&W
Scientific, Folsom, CA, USA). Helium was the carrier gas at a constant
flow rate of 1.5 ml/min. Injection (2 μl) was performed in splitless
mode at 280 °C. Nitrogen (60 ml/min) was the makeup gas. The elec-
tron capture detection was set at 310 °C. The oven temperature pro-
gram was held at 90 °C for 2 min, and then increased to 130 °C/min and
290 °C at 4 °C/min, with a final holding time of 20 min. The total run
time was 60.67 min. The limits of detection (LOD) of OC pesticides and
PCBs were 0.010–0.035 ng/ml.
PBDE congeners were analyzed by gas chromatography coupled
with mass spectrometry in chemical ionization mode and negative ion
recording (LOD: 0.001–0.025 ng/ml). The laboratory methods and
quality control procedures have been previously described (Gari and
Grimalt, 2010; Grimalt et al., 2010a). Total cholesterol and triglycer-
ides were determined in serum samples using colorimetric enzymatic
methods in the General Biochemistry Laboratory of San Agustin Hos-
pital (Asturias). The samples were processed using a Roche Diagnostics
COBAS C711 analyzer (Basel, Switzerland). Total serum lipid con-
centrations were calculated as previously described (Phillips et al.,
1989), using the following formula.
Total lipids = (2.27 × total cholesterol) + triglycerides + 62.3 mg/dl
Analytical results (including POPs and total lipid concentrations)
were validated by analysis of reference material obtained from the
Arctic Monitoring and Assessment Program.
2.3. Anthropometric measurements
AGD measurements were collected according to the protocol de-
veloped by Salazar-Martinez and colleagues (Salazar-Martinez et al.,
2004). The child was placed in the dorsal decubitus position; both hips
were flexed and light pressure was exerted on the thighs until the pe-
diatrician's hand touched the subject's abdomen. All measurements
were performed with Vernier calipers in increments of 0.1 mm by two
pediatricians (IRG and CRD) previously trained in the technique. The
examiners stood in front of the children and made independent mea-
surements of AGD using the same digital caliper. To evaluate inter-
examiner variability, two pediatricians took independent
Fig. 1. Flowchart of the participant selection process from the INMA Asturias cohort to be included in the present study.
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measurements of 10% of the entire sample following the same proce-
dure. The outputs did not substantially differ; therefore, only one
measurement was noted. AGD was measured from the center of the
anus to the posterior convergence of the fourchette (anofourchetal
distance, anus to fourchette) in female children, and from the center of
the anus to the junction of the smooth perineal skin with the rugated
skin of the scrotum (anoscrotal distance, anus to scrotum) in male
children.
2.4. Potential confounders
Participating women completed two detailed questionnaires during
their pregnancy (at 10–13 and 28–32 gestational weeks) and at the 4-
year follow-up. The questionnaires were administered by a trained in-
terviewer and covered sociodemographic, environmental, and lifestyle
factors. The maternal variables used as potential confounders in this
study were age, pre-pregnancy weight (self-reported), gestational age
(weeks) at delivery, gravidity (1, 2, or ≥3), education (primary, sec-
ondary, or university), and pre-pregnancy body mass index (BMI). Pre-
pregnancy BMI was obtained by dividing self-reported pre-pregnancy
weight in kg by current height in meters squared, and was categorized
as underweight (< 18.5 kg/m2), normal (18.5–24.9 kg/m2), over-
weight (25.0–29.9 kg/m2), or obese (≥30 kg/m2). Paternal covariates
included age and BMI. The questionnaires also included an assessment
of tobacco exposure: prenatal exposure to tobacco smoke (yes/no),
smoking at the beginning of pregnancy (yes/no), smoking at week 12 of
pregnancy (yes/no), and smoking at week 32 of pregnancy (yes/no).
Child covariates assessed for confounding included length/height,
weight at birth, and BMI at age 4 years.
2.5. Statistical analysis
Descriptive statistics were calculated for demographic and clinical
characteristics by maternal sample (n = 155) and cord sample
Table 1
Characteristics of mothers and children participating in the INMA-Asturias cohort study.
Variables Sub-sample with available data on maternal serum (n = 155) Sub-sample with available data on cord serum (n = 229)
Maternal characteristics N % Mean (SD) N % Mean (SD)
Age (years) 31.50 (4.45) 31.63 (4.14)
Gestational age (week) 39.81 (1.39) 39.68 (1.37)
Pre-pregnancy BMI
Underweight (< 18.5 kg/m2) 4 2.6 7 3.1
Normal (18.5–24.9 kg/m2) 106 68.4 158 69.0
Overweight (25.0–29.9 kg/m2) 33 21.3 47 20.5
Obese (≥30 kg/m2) 12 7.7 17 7.4
Height (cm) 162.62 (5.60) 162.48 (5.61)
Education
Primary 27 17.4 35 15.3
Secondary 66 42.6 93 40.6
Universitary 62 40.0 101 44.1
Gravidity
One 79 50.9 117 51.1
Two 41 26.5 70 30.5
Three or more 35 22.6 42 18.4
Smoking at 1st trimester of pregnancy
Yes 43 27.7 61 26.6
No 110 71.0 161 70.3
Maternal passive smoking
Yes 72 46.5 98 42.8
No 81 52.3 124 54.1
Smoking at week 12 of pregnancy
Yes 21 13.5 32 14.0
No 132 84.5 189 82.5
Smoking at week 32 of pregnancy
Yes 20 12.9 30 13.1
No 133 85.8 192 83.8
Paternal characteristics
Age (years) 33.10 (5.65) 33.98 (1.37)
BMI
Underweight (< 18.5 kg/m2) - - - -
Normal (18.5–24.9 kg/m2) 47 30.3 71 31
Overweight (25.0–29.9 kg/m2) 77 49.7 109 47.5
Obese (> 30 kg/m2) 26 16.8 40 17.4
Child characteristics
AGD at 4 years (mm)
Male 74 47.8 33.95 (10.65) 116 50.7 33.09 (11.38)
Female 81 52.2 16.48 (9.25) 113 49.3 16.00 (9.21)
AGI at 4-years (mm/kg)
Male 74 47.8 1.81 (0.58) 116 50.7 1.79 (0.62)
Female 81 52.2 1.07 (0.72) 113 49.3 1.04 (0.62)
Birth weight (kg) 3.35 (4.39) 3.32 (4.39)
Birth length (cm) 49.92 (1.90) 49.91 (1.86)
Height at 4 years (cm) 106.31 (4.47) 106.03 (4.44)
Weight at 4 years (kg) 18.57 (2.94) 18.28 (2.93)
BMI at 4 years (kg/m2) 16.36 (1.77) 16.20 (1.82)
SD, standard deviation; BMI, body mass index; AGD, anogenital distance; AGI, anogenital index.
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(n = 229). Summary statistics were calculated for continuous variables
and categorical variables were presented as n (%).
We used the anogenital index (AGI; calculated as AGD divided by
weight at age of examination [mm/kg]) as previously described (Swan
et al., 2005). The AGI was normally distributed and treated as the de-
pendent variable in the linear regression models. Statistical analyses
were stratified by child's sex for both maternal serum and cord serum
samples. POP levels were expressed in nanograms per milliliter (ng/ml)
and adjusted by total serum lipid concentrations (nanograms per gram
lipid, ng/g lipid), and then natural-log transformed to reduce skewness
before being introduced in the linear regression models. Although POPs
concentrations standardized by lipid content are widely used in POPs
relevant analysis, we have repeated the analysis with POPs concentra-
tions expressed on a volume basis (ng/ml), with total serum lipids as a
covariate and as a sensitivity analysis. Spearman's coefficients were
calculated for each POP pair. We calculated the sum of maternal and
cord DDT (∑DDTs; i.e., 4,4′-DDE, 4,4′-DDT, 4,4′-DDD), PCBs (∑PCBs;
i.e., PCB-28, -101, −118, −138, −153, −180), and PBDE (∑PBDEs;
i.e., PBDE-28, -47, −99, −153, −154, −209) as biomarkers of ∑POPs
exposure and they were used as global indicators of exposure to dif-
ferent groups of POPs.
Covariates used as potential confounders in our models were based
on prior studies using direct acyclic graphs and selecting the minimally
sufficient adjustment set (Figure S4) (Textor et al., 2016). In both males
and females, models were adjusted by height at age 4 years, maternal
height, maternal pre-pregnancy BMI, and maternal gravidity, as well as
by the ∑DDTs, ∑PCBs, and ∑PBDEs (excluding the family of compounds
–∑– to which the dependent variable belonged). Interactions between
the compounds PBDE-99, PCB-138, and 4,4′-DDE (in pairs) were in-
troduced into the model if associations were statistically significant at
α = 0.05. To examine the associations between POPs and AGI, com-
pounds with a detection rate> 50% were categorized according to
tertiles, whereas those with a detection rate< 50% were divided de-
pending on whether the value was below or above the LOD. P-trends
across tertiles of POPs were obtained by including the median of each
quartile as a continuous variable in the linear regression models. Values
below the lower LOD were entered as the LOD divided by the square
root of 2 and included in statistical analyses. For hypothesis testing,
p < 0.05 (both main effects and interactions) was considered statis-
tically significant. The Benjamini-Hochberg procedure was used to
control for false discovery rate (Benjamini and Hochberg, 1995). We
used the Variance Inflation Factor (VIF) to study the multicollinearity of
the linear regression models (Fox and Weisberg, 2019). All statistical
analyses and graphics were performed using R version 3.5.1 (R Core
Team, 2014).
3. Results
Table 1 summarizes the physiological and sociodemographic vari-
ables of the mothers, fathers, and children in the INMA Asturias study.
The median maternal age was 31.5 years (range: 19–42 years) and
mean (standard deviation [SD]) maternal height and weight were 162.6
(5.60) cm and 63.14 (10.96) kg, respectively. Approximately 28% of
mothers were overweight or obese, and 40% had a university education
at delivery. Regarding tobacco use, 46.5% were passive smokers and
27.7% were smokers at the beginning of pregnancy, but only 13.5%
were smokers at week 12 of pregnancy and 12.9% at week 32. Chil-
dren's mean (SD) height, weight, and BMI at age 4 years were 106.3
(4.47) cm, 18.57 (2.94) kg, and 16.36 (1.77) kg/m2, respectively. The
mean (SD) birth weight was 3.35 (4.39) kg and mean (SD) birth length
was 49.92 (1.90) cm. No genital malformations or disorders were ob-
served in the evaluated children, and no parameter appeared grossly
abnormal in any child. The AGD in males was 13–62 mm, with a mean
(SD) distance of 33.95 (10.65) mm. In females, the mean (SD) AGD was
16.48 (9.25) mm (range: 10–30 mm). The mean (SD) AGI was 1.81
(0.58) mm/kg in males and 1.07 (0.72) mm/kg in females. The de-
scriptive analyses results were similar among those with cord serum
samples (Table 1).
Table 2 summarizes maternal serum and cord serum levels for two
HCH isomers, HCB, DDT and its metabolites, six PCB congeners, and six
PBDE congeners. In maternal serum, HCB, β-HCH, PCB-138, PCB-153,
and PCB-180 were detected in all samples, and 4,4′-DDE, 4,4′-DDT,
PCB-28, PCB-118, PBDE-153, and PBDE-154 were detected in the ma-
jority (> 75%) of samples. The detection frequency of the other ana-
lyzed compounds ranged from 10% to 60%. In general, POPs levels and
detection rates were lower in cord serum samples. Only PCB-138 and
PCB-153 were detected in all cord serum samples. The detection rates of
HCB, β-HCH, 4,4′-DDE, 4,4′-DDT, PCB-118, and PCB-180 were ≥90%.
The detection rate of the other compounds was 4%–63%. Spearman's
correlations between maternal and cord serum paired samples ranged
from weakly negative to strongly positive (Spearman rho [ρ] = −0.04
to 0.91, Figure S1). No correlation was observed for PBDE
Table 2
Detection rate and levels of persistent organic pollutants (POPs) (ng/g lipid) in maternal and cord blood serum, INMA-Asturias cohort.
POP levels LOD (ng/ml) Maternal serum Cord serum
%(> LOD) Median 5th 95th CV %(> LOD) Median 5th 95th CV
HCB 0.0151 100 75.05 24.48 216.49 0.75 98.69 50.33 17.68 175.89 0.74
β-HCH 0.001 100 24.95 7.96 88.94 1.08 93.01 17.37 0.29 68.20 1.08
γ-HCH 0.0183 10.32 2.44 1.81 7.60 0.71 4.37 5.01 3.83 6.90 0.49
44-DDD 0.003 40.00 0.36 0.23 3.38 1.25 13.97 0.63 0.48 4.46 2.40
44-DDE 0.0081 99.35 254.67 83.83 1071.43 1.21 99.13 178.82 52.31 824.71 1.07
44-DDT 0.0247 94.19 19.53 4.29 55.67 2.24 96.51 33.38 10.72 130.91 11.26
PCB-28 0.0064 74.84 3.72 0.38 16.72 1.03 14.41 0.93 0.71 5.11 1.39
PCB-101 0.0225 58.71 5.23 1.26 24.32 1.00 62.88 33.12 2.99 59.14 0.52
PCB-118 0.0286 94.84 10.33 2.56 27.74 0.65 89.52 6.76 2.26 20.57 1.09
PCB-138 0.0173 100 37.31 15.92 85.02 0.56 100 32.55 12.04 91.14 2.34
PCB-153 0.0215 100 66.07 32.05 131.52 0.49 100 47.7 18.64 116.42 0.62
PCB-180 0.0103 100 48.28 13.09 111.48 0.67 97.82 27.79 7.16 68.85 0.96
PBDE-28 0.0015 21.94 0.16 0.11 1.69 1.45 17.47 0.31 0.24 2.11 2.13
PBDE-47 0.0025 20.65 0.26 0.19 5.62 2.53 34.06 0.56 0.41 5.46 4.04
PBDE-99 0.0023 59.35 1.63 0.19 11.28 1.47 28.82 0.50 0.37 9.45 3.00
PBDE-153 0.0027 86.45 2.52 0.15 9.55 1.81 14.41 0.30 0.2 3.35 3.31
PBDE-154 0.0012 93.55 2.60 0.25 11.14 1.06 44.54 0.57 0.42 3.92 2.58
PBDE-209 0.0091 37.42 1.02 0.72 14.53 1.58 13.54 1.87 1.40 16.18 1.97
HCB, hexachlorobenzene; HCH, hexachlorocyclohexane; 4,4′-DDD, 1,1-bis(4-chlorophenyl)-2,2-dichloroethane; 4,4′-DDE, 2,2-bis(4-chlorophenyl)-1,1-di-
chloroethene; 4,4′-DDT, 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane; PCB, polychlorinated biphenyl; PBDE, polybrominated diphenyl ethers.
LOD, limit of detection; 5th, percentile 5; 95th, percentile 95; CV, coefficient of variation.
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concentrations between maternal serum and sum of PCBs or sum of
DDTs. The concentrations of PCBs in maternal serum were not strongly
correlated with ΣDDTs and ΣPBDEs (ρ = 0 to 0.36 and 0.12 to 0.20,
respectively). In addition, 4,4′-DDT and its derivates did not exhibit
statistically significant correlations with ΣPCBs and sum of ΣPBDEs
(ρ = 0.05 to 0.36) (Figure S2B). No substantial correlation differences
were observed when considering the concentrations in cord serum
(Figure S3).
The AGI of male offspring was inversely associated with maternal
serum concentrations of the second tertile of PCB-138 (β = −0.041,
95% confidence interval [CI]: −0.074, −0.008), second tertile of PCB-
153 (β=−0.052, 95% CI:−0.085, −0.020), and the second and third
tertiles of PCB-180 (β = −0.065, 95% CI: −0.096, −0.035 and
β = −0.042, 95% CI: −0.073, −0.011, respectively), and PBDE-209
(β = −0.031, 95% CI: −0.058, −0.006) (Table 3). PCB-153
(β = −0.029, 95% CI: −0.59, −0.000 and β = −0.047, 95% CI:
−0.085, −0.008, second and third tertiles, respectively) and PCB-180
(β = −0.041, 95% CI: −0.078, −0.005) in cord serum samples were
also associated with a lower AGI value (Table 4). Furthermore, for PCB-
153 and PCB-180, the interaction between PCB-138 and 4,4′-DDE was
statistically significant (p= 0.01 and p= 0.03, respectively). However,
a statistically significant positive association was found between PBDE-
153 in cord serum samples and AGI (β = 0.023, 95% CI: 0.001, 0.045)
(Table 4). In females, the AGI was positively related to maternal serum
concentrations in the second tertile of PCB-101 (β = 0.039, 95% CI:
0.002, 0.076) (Table 3) and cord serum concentrations in the third
Table 3
Association between prenatal exposure to persistent organic pollutants measured in maternal blood and anogenital index at 4 years of age.
Maternal serum Male1 Female1
POP (ng/g lipid) Beta 95% CI p-value p-trend Beta 95% CI p-value p-trend
HCB (ref: ≤ T1)
T2: 51.72–91.36 0.003 −0.031 0.036 0.850 −0.011 −0.053 0.030 0.588
T3: > 91.36 0.011 −0.032 0.054 0.612 0.608 −0.008 −0.050 0.033 0.683 0.671
β-HCH (ref: ≤ T1)
T2: 20.60–38.50 −0.010 −0.045 0.024 0.548 −0.020 −0.061 0.022 0.351
T3: > 38.50 −0.017 −0.052 0.018 0.336 0.333 −0.017 −0.066 0.032 0.491 0.493
44-DDE (ref: ≤ T1)
T2: 200.61–355.84 −0.014 −0.047 0.019 0.392 0.034 −0.007 0.074 0.100
T3: > 355.84 0.004 −0.030 0.039 0.803 0.757 0.029 −0.012 0.070 0.163 0.151
44-DDT (ref: ≤ T1)
T2: 13.04–25.83 0.010 −0.021 0.044 0.489 0.032 −0.009 0.073 0.121
T3: > 25.83 0.025 −0.008 0.059 0.128 0.122 0.024 −0.019 0.066 0.266 0.284
PCB-28 (ref: ≤ T1)
T2: 1.65–5.52 0.010 −0.019 0.040 0.460 0.011 −0.029 0.051 0.588
T3: > 5.52 0.010 −0.023 0.040 0.520 0.495 0.023 −0.015 0.060 0.231 0.228
PCB-101 (ref: ≤ T1)
T2: 1.80–8.61 0.010 −0.023 0.045 0.518 0.039 0.002 0.076 0.041
T3: > 8.61 −0.007 −0.038 0.025 0.664 0.634 0.008 −0.032 0.047 0.701 0.621
PCB-118 (ref: ≤ T1)
T2: 7.59–13.90 −0.014 −0.050 0.022 0.444 −0.016 −0.058 0.026 0.451
T3: > 13.90 0.009 −0.022 0.040 0.560 0.457 0.027 −0.014 0.068 0.193 0.127
PCB-138 (ref: ≤ T1)
T2: 30.15–46.64 −0.041 −0.074 −0.008 0.017 −0.029 −0.046 0.034 0.149
T3: > 46.64 −0.022 −0.061 0.009 0.136 0.218 −0.006 −0.057 0.021 0.745 0.727
PCB-153 (ref: ≤ T1)
T2: 53.50–76.44 −0.052 −0.085 −0.020 0.002a 0.031 −0.008 0.070 0.126
T3: > 76.44 −0.024 −0.057 0.008 0.134 0.204 −0.006 −0.045 0.034 0.775 0.695
PCB- 180 (ref: ≤ T1)
T2: 36.50–58.50 −0.065 −0.096 −0.035 <0.001a −0.006 −0.046 0.034 0.782
T3: > 58.40 −0.042 −0.073 −0.011 0.009a 0.046 −0.018 −0.057 0.021 0.368 0.360
PBDE-99 (ref: ≤ T1)
T2: 0.26–3.06 0.019 −0.010 0.048 0.197 0.017 −0.025 0.060 0.426
T3: > 3.06 0.000 −0.036 0.036 0.988 0.748 −0.015 −0.054 0.024 0.451 0.313
PBDE-153 (ref: ≤ T1)
T2: 1.94–3.52 −0.002 −0.034 0.031 0.923 0.010 −0.033 0.053 0.634
T3: > 3.52 0.004 −0.028 0.036 0.800 0.802 0.025 −0.016 0.066 0.227 0.218
PBDE-154 (ref: ≤ T1)
T2: 1.68–3.92 −0.004 −0.033 0.025 0.766 0.022 −0.019 0.039 0.278
T3: > 3.92 0.002 −0.031 0.036 0.896 0.938 −0.001 −0.041 0.049 0.945 0.883
γ-HCH (ref: ≤LOD)
>LOD: 0.020 −0.008 −0.038 0.081 0.079 - −0.026 −0.077 0.024 0.297 -
44-DDD (ref: ≤LOD)
>LOD: 0.003 −0.008 −0.034 0.018 0.531 - −0.006 −0.039 0.027 0.732 -
PBDE-28 (ref: ≤LOD)
>LOD: 0.001 −0.010 −0.043 0.023 0.534 - 0.008 −0.029 0.045 0.675 -
PBDE-47 (ref: ≤LOD)
>LOD: 0.003 0.003 −0.037 0.042 0.890 - 0.003 −0.033 0.040 0.849 -
PBDE-209 (ref: ≤LOD)
>LOD: 0.010 −0.031 −0.058 −0.006 0.016 - −0.014 −0.049 0.020 0.415 -
LOD, limit of detection; T1, 1st tertile; T2, 2nd tertile: T3, 3rd tertile; β, regression coefficient; p-trend: P for trend from a linear regression model where the AGI was
the outcome of interest and POPs variable was the predictor (continuous). CI: confidence interval. 1adjusted by height at age 4 years, maternal height, pre-pregnancy
body mass index, gravidity, and ΣDDTs (sum of 4,4′-DDE, 4,4′-DDT, and 4,4′-DDD), ΣPCBs (sum of PCB-28, -101, −118, −138, −153, and −180), and/or ΣPBDEs
(sum of PBDE-28, -47, −99, −153, −154, and −209). a Applying Benjamini and Hochberg's procedure keeps the p-values significant.
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tertile of 4,4′-DDE (β = 0.032, 95% CI: 0.003, 0.061) and third tertile
of 4,4′-DDT (β = 0.040, 95% CI: 0.011, 0.069) (Table 4). When using
POPs concentration expressed on a volume basis (ng/ml) with total
serum lipids as a covariate, the results were similar to those using lipid
adjusted concentrations.
4. Discussion
This study provided epidemiological evidence that prenatal ex-
posure to PCB-138, PCB-153, PCB-180, and PBDE-209 in the first tri-
mester was associated with a shorter AGI in 4-year-old boys. In girls,
the AGI was positively associated with maternal serum concentrations
of PCB-101, and 4,4′-DDT and 4,4′-DDE concentrations in cord blood
serum at delivery. Pre/perinatal exposure to POPs could be associated
with shortened AGI in male offspring and with lengthened in females.
Gestation is a stage of vulnerability to EDCs, as even low levels of
these compounds may produce irreversible damage (Costa et al., 2016;
Legler, 2008). In this respect, the first trimester of pregnancy is a cri-
tical period for the differentiation of external genitalia, which occurs in
males when appropriate androgen levels are reached. The biological
mechanism for this has been widely studied in the literature (Agramunt
et al., 2011; Thankamony et al., 2016). If this process is incomplete, it
may result in genital tract malformation and be related to shortened
AGD in males, because it reflects diminished androgenization during
development (Freire et al., 2018). AGD is a sexually dimorphic trait and
is therefore a marker of prenatal estrogenic or androgenic influence that
can be used as an index of the anti-androgenic or anti-estrogenic effects
produced by EDCs in humans (Dean and Sharpe, 2013; Mendiola et al.,
2016; Salazar-Martinez et al., 2004; Yang et al., 2010). In male off-
spring, androgenicity is typically measured by testicular volume and
penile dimensions rather than AGD (Longnecker et al., 2007). However,
human data suggest AGD may be responsive to androgenic exposures in
Table 4
Association between prenatal exposure to persistent organic pollutants measured in cord blood and anogenital index at 4 years of age.
Cord Serum Male1 Female1
POP (ng/g lipid) Beta 95% CI p-value p-trend Beta 95% CI p-value p-trend
HCB (ref: ≤ T1)
T2: 37.81–70.69 −0.009 −0.036 0.018 0.499 −0.001 −0.031 0.029 0.952
T3: > 70.69 0.011 −0.021 0.044 0.484 0.493 0.003 −0.029 0.035 0.845 0.841
Β-HCH (ref: ≤ T1)
T2: 11.62–25.19 0.029 0.001 0.057 0.402 0.000 −0.028 0.027 0.975
T3: > 25.19 0.006 −0.022 0.035 0.661 0.659 0.007 −0.023 0.038 0.648 0.065
44-DDE (ref: ≤ T1)
T2: 132.13–259.79 −0.016 −0.043 0.011 0.249 0.007 −0.021 0.034 0.633
T3: > 259.79 0.005 −0.022 0.032 0.711 0.652 0.032 0.003 0.061 0.033 0.034
44-DDT (ref: ≤ T1)
T2: 24.11–47.26 −0.010 −0.039 0.019 0.499 −0.002 −0.029 0.025 0.881
T3: > 47.26 −0.004 −0.035 0.026 0.772 0.844 0.040 0.011 0.069 0.006a 0.010
PCB-101 (ref: ≤ T1)
T2: 27.16–39.02 −0.006 −0.032 0.019 0.626 0.001 −0.027 0.030 0.917
T3: > 39.02 0.000 −0.027 0.027 0.986 0.966 −0.004 −0.032 0.023 0.749 0.742
PCB-118 (ref: ≤ T1)
T2: 3.27–8.77 −0.012 −0.038 0.014 0.361 −0.027 −0.054 0.000 0.053
T3: > 8.77 −0.003 −0.029 0.023 0.821 0.819 −0.024 −0.051 0.003 0.084 0.085
PCB-138 (ref: ≤ T1)
T2: 25.72–40.82 0.004 −0.023 0.031 0.785 −0.007 −0.034 0.020 0.605
T3: > 40.82 −0.003 −0.031 0.025 0.833 0.822 −0.027 −0.056 0.003 0.081 0.084
PCB-153 (ref: ≤ T1)
T2: 40.41–61.07 −0.029 −0.059 0.000 0.049b −0.002 −0.030 0.025 0.859
T3: > 61.07 −0.047 −0.085 −0.008 0.017b 0.016 −0.023 −0.052 0.006 0.122 0.118
PCB- 180 (ref: ≤ T1)
T2: 19.82–36.42 −0.011 −0.040 0.018 0.463 0.025 −0.004 0.054 0.091
T3: > 36.42 −0.041 −0.078 −0.005 0.027b 0.025 0.010 −0.032 0.052 0.639 0.464
γ-HCH (ref: ≤LOD)
>LOD: 0.020 0.035 −0.033 0.104 0.311 - −0.006 −0.056 0.045 0.818 -
44-DDD (ref: ≤LOD)
>LOD: 0.003 0.001 −0.028 0.030 0.935 - −0.001 −0.039 0.037 0.966 -
PCB-28 (ref: ≤LOD)
>LOD: 0.006 −0.025 −0.055 0.004 0.085 - −0.009 −0.042 0.024 0.596 -
PBDE-28 (ref: ≤LOD)
>LOD: 0.001 −0.020 −0.051 0.011 0.197 - −0.005 −0.032 0.023 0.727 -
PBDE-47 (ref: ≤LOD)
>LOD: 0.003 0.009 −0.014 0.033 0.425 - −0.008 −0.031 0.016 0.521 -
PBDE-99 (ref: ≤LOD)
>LOD: 0.002 0.014 −0.009 0.037 0.222 - −0.014 −0.038 0.011 0.268 -
PBDE-153 (ref: ≤LOD)
>LOD: 0.003 0.023 0.001 0.045 0.037 - −0.021 −0.043 0.000 0.051 -
PBDE-154 (ref: ≤LOD)
>LOD: 0.001 0.005 −0.026 0.036 0.764 - −0.009 −0.040 0.023 0.592 -
PBDE-209 (ref: ≤LOD)
>LOD: 0.010 0.026 −0.003 0.056 0.083 - −0.006 −0.042 0.029 0.71 -
LOD, limit of detection; T1, 1st tertile; T2, 2nd; tertile: T3, 3rd tertile; β: regression coefficient; p-trend: P for trend from a linear regression model where the AGI was
the outcome of interest and POPs variable was the predictor (continuous). CI: confidence interval. 1Adjusted by height at age 4 years, maternal height, pre-pregnancy
body mass index, gravidity, and ΣDDTs (sum of 4,4′-DDE, 4,4′-DDT, and 4,4′-DDD), ΣPCBs (sum of PCB-28, -101, −118, −138, −153, and −180), and/or ΣPBDEs
(sum of PBDE-28, -47, −99, −153, −154, and −209. a Applying Benjamini and Hochberg's procedure keeps the p-values significant. b In males, associations with
PCB-153 and PCB-180 were adjusted by the interaction between 4,4′-DDE and PCB-138.
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utero, and that AGD is more reliable than penile dimensions (Salazar-
Martinez et al., 2004; Swan et al., 2005).
In the present study, we used a previously published protocol for
measuring AGD (Salazar-Martinez et al., 2004) because the anatomical
landmarks are easily identifiable. The mean AGD in 4-year-old males
was 33.95 mm, which was comparable with data reported in the UK
(Thankamony et al., 2009), Nigeria (Avidime et al., 2011), the US
(Wenzel et al., 2018), South Africa (Bornman et al., 2016), and China
(Luan et al., 2019). However, the AGIs in the present study were 3–4
times lower than those reported in other studies conducted among
newborns and 2-year-old children (Huang et al., 2009; Swan et al.,
2015, 2005; Torres-Sanchez et al., 2008). Therefore, available data
show variations between AGD measured in geographically distinct po-
pulations, most likely because of ethnic factors or different measuring
devices or measurement techniques (i.e., anoscrotal, anopenile). Dif-
ferences may also be influenced by the ages at which the measurements
were collected, and could also be explained by the influence of weight
on children's growth. In particular, the high prevalence of obesity in our
study population (Riaño-Galán et al., 2017) could be a factor influen-
cing the AGI.
Our results for males showed a negative association between AGI
and exposure to PCB-138, PCB-153, PCB-180, and PBDE-209. These
findings were supported by a human study conducted in Mexico that
evaluated the associations between AGD/height during the first year of
life and PCBs and DDT concentrations in maternal venous serum col-
lected in the third trimester of pregnancy (Loreto-Gómez et al., 2018).
That study found noteworthy negative associations between PCB-28,
PCB-74, and PCB-170 and AGD/height in males. Similarly, notable in-
verse associations between anoscrotal distance and fourth-quartile
PBDE-47 cord plasma concentrations in male children aged 12 and 48
months were reported in China (Luan et al., 2019). Other studies fo-
cused on persistent compounds found high dioxin-like activity in ma-
ternal blood were associated with shortened AGD in newborn boys,
indicating that dioxins may generate endocrine-disrupting effects in
male infants (Vafeiadi et al., 2013). Maternal serum DDT concentra-
tions at delivery were also associated with larger penile measurements
in male offspring at 12 months (Bornman et al., 2016). Another study
reported an association between maternal venous concentrations of
DDE and a reduction in the anal position index, which is another metric
for measuring the effects of chemicals on reproductive organs in males
(Torres-Sanchez et al., 2008). However, Longnecker and colleagues did
not find a clear association between AGD and maternal blood DDE le-
vels (Longnecker et al., 2007). The differences in time of AGD mea-
surements made the comparison between other studies and our study
difficult. In addition, the relatively low exposure level in our study may
also make it difficult to explore the potential association between POPs
and AGI.
Recent work in the INMA-Asturias cohort found inverse associations
between AGI at 18 months and exposure levels of PBDE-153 and PBDE-
99 in maternal venous blood (García-Villarino et al., 2018). Although it
is possible that the shorter AGD associated with higher exposures of
POPs may be related to a feminizing effect, the mechanism of action
and the effects of these compounds have not yet been identified.
However, the results from human studies were consistent with those
from animal studies, showing that exposure to phthalates, PCBs, di-
oxins, and PBDEs may affect fetal development (Jin et al., 2008;
Rosenberg et al., 2008; Saillenfait et al., 2009). POPs (i.e., DDE, PCBs,
and PBDEs) have been reported to be anti-androgenic in in-vitro and in-
vivo assays (Hoffmann and Kloas, 2016; Stoker et al., 2005). In rats,
prenatal exposure to PCBs led to dose-dependent decreases in steroid
hormone levels (Kaya et al., 2002), supporting the hypothesis that PCBs
interfere with androgen-induced transcriptional activation and hor-
mone binding (Portigal et al., 2002). The anti-androgenic activity of
DDT and its derivates has also been studied in animals, with results
showing that prenatal exposure led to shortenings of AGD in male rats
(Hoffmann and Kloas, 2016). Prenatal PBDE-99 exposure has also been
shown to be related to shorter AGD in male rats (Lilienthal et al., 2006).
Evidence suggests that PBDEs exposure could downregulate steroido-
genic proteins, decrease androgen levels, and inhibit Leydig cells tes-
tosterone synthesis and androgen receptor (AR) binding. Prenatal an-
drogen levels are associated with a shortened AGD (Moore et al., 2001);
a possible mechanism underlying the adverse effects of PBDEs on AGD
is the antiandrogenic effect caused by the decrease in androgen levels.
Another potential mechanism of PBDEs may be explained by estrogenic
pathways, which also has been suggested in previous studies exploring
the effects of estrogenic (Dang et al., 2007; Meerts et al., 2001), anti-
estrogenic (Meerts et al., 2001), and even anti-androgenic (Stoker et al.,
2005) activity.
Among females, very low levels of androgens, an absent or an in-
active AR are necessary for external genitalia differentiation (Speroff
et al., 1999). In addition, according to the rodent model of inactivated
estrogen alpha receptor gene (ERα), estrogen action seems to be ne-
cessary for the final female morphology (Yang et al., 2010). In our
study, the mean measured AGD for females was 16.48 mm, which was
similar than the AGD reported in other studies carried out in Mexico
(Loreto-Gómez et al., 2018; Salazar-Martinez et al., 2004), in the US
(Barrett et al., 2017; Callegari et al., 1987; Wenzel et al., 2018), and in
Israel (Phillip et al., 1996). The mean AGI for girls in the present study
was lower than that reported in Taiwan (Huang et al., 2009). As for
results pertaining to males, differences in AGD in these studies may be
explained by different measuring devices or measurement techniques
(i.e., anofourchette or anoclitoral distance), age at examination, body
size, and ethnicity.
To our knowledge, no human studies have previously linked PCB or
PBDE exposure to AGD in females. Our data showing a meaningfully
increased AGD in girls exposed to 4,4′-DDE, 4,4′-DDT, and PCB-101
may be the first findings suggesting a role of estrogen action during
human female external genitalia development. In particular, 4,4′-DDE is
best known for its estrogenic activity (Chen et al., 1997; Kuiper et al.,
1998), and the mechanisms underlying the relationship between pre-
natal 4,4′-DDE and AGD are uncertain. A possible explanation is that
the balance between the estrogenic and anti-androgenic effect of DDE is
marked by increased estrogenic activity. Evidence suggests that ex-
posure to DDT/DDE is associated with younger age at menarche and
increased incidence of shortened menstrual cycles (Ouyang et al.,
2005). A South African study found maternal serum DDT concentra-
tions at delivery were associated with shorter AGD in female offspring
(Bornman et al., 2016), which contrasts with our findings, perhaps
because of higher environmental DDT levels in South Africa. Maternal
exposure to bisphenol A (BPA) has been associated with shorter dis-
tance from the center of the anus to the clitoris in newborn females, but
no association was found between maternal BPA and infant distance
from the center of the anus to the fourchette (Barrett et al., 2017). This
study hypothesized that prenatal exposure to EDCs may affect AGD
through estrogenic pathways, which may explain our results. Andro-
genic environments during gestation can develop masculinization,
generating females with higher AGD (Hotchkiss et al., 2007; Wolf et al.,
2002).
Studies in female animals support the hypothesis that prenatal ex-
posure to compounds with androgenic activity results in longer AGD
(Dean et al., 2012; Wolf et al., 2002; Wu et al., 2010), perhaps because
exposure to androgens or estrogens can regulate their own expression of
the receptor; that is, estrogens/androgens can act in a differentiated
way and the expression of the receptor of one of them can be repressed.
This idea is supported by studies on ERα knockout in mouse females
that in the absence of estrogen action, showed masculinized external
genitalia that was explained by a balance between sex hormones during
pregnancy; for a long time, it was thought that female genitalia re-
present the default state (Yang et al., 2010). In humans, no such model
of ERα absence with slightly virilized external genitalia at birth has
been described. However, this is an extremely rare genetic condition in
which virilization signs have been described in adults in the context of
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increased testosterone production from polycystic ovaries (Quaynor
et al., 2013). As genital development models in rodents reproduce
human ones, it may be that external genitalia in human females with
ERα at birth or prepuberty have not yet been explored.
We previously observed that OC compounds (Lopez-Espinosa et al.,
2016) and PBDEs (Lopez-Espinosa et al., 2015) can interfere in fetal
growth and be transported across the placenta (Vizcaino et al., 2014a).
We also observed that PBDE-99 and PBDE-153 were associated with
reduced AGD in males at age 18 months (García-Villarino et al., 2018).
Differences in the results from this study and our previous work may be
explained by the difference in the sample size and by the inclusion of
interactions with other compounds in the present study. The interac-
tions studied in our models evaluated the synergistic effect of the
concentration of compounds such as 4,4-DDE, PCB-138, or PBDE-99.
All of these are considered potent antiandrogenic agents (Lilienthal
et al., 2006; Portigal et al., 2002; Torres-Sanchez et al., 2008). One
potential explanation for this interaction is that higher levels of each
compound (PCB-138 and 4,4′-DDE) might induce the decrease of AGI in
males and the interactions effects appear to be synergistic, which may
be of significance given the common coexposures to multiple con-
taminants. It is not clear, however, which pathways participate in this
mechanism, so further investigation is needed. Nevertheless, in this
study and our previous study, we showed that prenatal exposure to
POPs was inversely associated with AGI in boys, which was consistent
with most scientific literature published to date. In addition, there is a
strong maternal-fetal correlation for the concentration of these pollu-
tants measured in both matrices of the present study. This is consistent
with the transfer of pollutants from mother to fetus (Vizcaino et al.,
2014a), which may explain why AGI in males was associated with PCB-
153 and PCB-180 in both maternal and cord serum samples. However,
this finding has not been confirmed in females, which may be attribu-
table to the small sample size for maternal serum compared with cord
serum and the relatively low exposure level in our study. This may
make the exploration of potential association difficult. Furthermore, the
effects of POPs on AGD may be time-delayed in females, because at age
4 years we found some associations that had not been observed in our
previous study at age 18 months. Individual susceptibility may also play
a role in the effects of these hormonally active agents.
Several limitations of this study should be noted. It is possible that
our sample size lacked the power to detect associations because stra-
tified our study population by the sex of the children, which decreased
the sample size. Interactions with compounds such as phthalates, PCB-
like dioxins, BPA, or perfluoroalkyl substances and residual con-
founders could also have affected the association between the pollu-
tants we studied and AGD (Luan et al., 2019; Sun et al., 2018). AGD
measurements were performed by two pediatricians, leading to possible
variability in the results, which could also be affected by the child's
movements during the physical examination. However, only one mea-
surement for each AGD was recorded, as assessment of intra-rater re-
liability (10% of the sample) showed no substantial bias. Another
limitation was the possibility of false positive results; it should be noted
that if there was actually no association between AGI and any POP, we
would obtain around 3.6 out of 72 p-values lower than 0.05. Never-
theless, we obtained four statistically significant results after applying
the Benjamini-Hochberg procedure, that is a powerful tool that de-
creases the false discovery rate. A major strength of this study was the
longitudinal cohort design with a long follow-up period and good
participation rates (94% participation rate). No clear pattern of dose-
response relationship was observed in our study. But the stronger and
more accurate effects of some congeners for the second and third ter-
tiles might be explained by the fact that hormones have complicated
concentration-response patterns, and these lay the foundation for the
dose-response characteristics exhibited by EDCs (Gore et al., 2015).
These endocrine characteristics demonstrate why it is difficult to define
the power of an EDC, why action thresholds are not possible to identify,
and why non-linear dose responses cannot be ignored, despite the
continuing controversy on this point. Measurements of AGD were taken
at 18 months and 4 years, with maternal samples collected in the first
trimester of pregnancy, which is possibly the most important period for
fetal reproductive system development. This study also contributed
data on AGD at an age that has not previously been investigated and
included data for female children, which to date have been scarce. We
measured a large number of OC and brominated compounds in both
maternal blood serum and cord blood serum, and analyzed summed
congeners and the interaction between compounds (i.e., 4,4′-DDE, PCB-
138, and PBDE-99) because they are compounds that have a high anti-
androgen capacity and that have been reported to have an effect on the
AGD. VIF values greater than 10 would indicate that the linear re-
gression model presents a degree of worrying multicollinearity, in the
case of our models the VIF values vary in the range between 1.12 and
7.34 and therefore do not present a multicollinearity. Lastly, to capture
the complex nature of environmental exposure as a whole, it might be
necessary to move from a single-pollutant to a multipollutant approach.
In summary, our findings provide evidence of inverse associations
between specific POPs and AGI in boys and positive association in girls
at age 4 years, perhaps through a feminizing effect in males and a
masculinizing effect in females. These findings are consistent with
previous rodent and human studies. Whether the changes we observed
in AGI persist throughout life and contribute to clinically relevant re-
sults (e.g., endometriosis or testicular cancer) should be further in-
vestigated and confirmed in subsequent studies.
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